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From the Society for Vascular Surgery
Gender-related outcomes in the endovascular
treatment of infrainguinal arterial obstructive
disease
Raffaele Pulli, MD,a Walter Dorigo, MD,a Giovanni Pratesi, MD,b Aaron Fargion, MD,a
Domenico Angiletta, MD,c and Carlo Pratesi, MD,a Florence, Rome, and Bari, Italy
Objective:The purpose of this study was to retrospectively analyze early andmidterm results of endovascular infrainguinal
peripheral revascularizations in female patients in our single-center experience, paying particular attention to clinical,
anatomic, and technical factors affecting perioperative and follow-up outcomes.
Materials and Methods: From January 2000 to December 2010, 258 endovascular interventions for femoropopliteal
disease were performed. Interventions were retrospectively divided into two groups: interventions performed in women
(80 interventions, group 1) and interventions performed inmen (178 interventions, group 2). The two groups of patients
were compared in terms of demographic data, common risk factors for atherosclerosis, and comorbidities. Early
(intraoperative and <30-day) results were analyzed in terms of technical success, conversion to open surgery, primary
patency, secondary patency, and, for patients with critical limb ischemia, limb salvage. The follow-up program consisted
of clinical and duplex scanning examinations with ankle-brachial index (ABI)measurement within the third postoperative
month, at 6 and 12 months, and yearly thereafter. Follow-up results were analyzed in terms of survival, primary and
secondary patency, assisted primary patency, and, for patients with critical ischemia, limb salvage.
Results: There were no differences between the two groups in terms of risk factors for atherosclerosis, comorbidities,
clinical, and anatomic status. Technical success was 96.9% and technical failure rates were 1.2% in group 1 and 3.9% in
group 2 (P .2). Three in-hospital deaths were recorded, all in group 2, whereas in-hospital thromboses occurred in five
patients, two in group 1 and three in group 2; with conversion to surgical bypass in all these cases, and in three of the
cases, major amputation was necessary (two in group 1 and one in group 2). Cumulative 30-day mortality was 1.1%, with
no difference between women (no deaths) and men (three deaths, 1.6%; P  .4). Overall amputation rate at 30 days was
1.2%, again with no differences between the two groups (2.5% and 0.6%, respectively; P  .4); also, the rate of
perioperative thrombosis (overall 2.7%) was similar between the two groups (2.5% and 3.3%, respectively; P  .9). Mean
duration of follow-up was 17 months (range, 1-85 months). Estimated 36-month survival rates were 95% in group 1 and
84.5% in group 2 (P  .4; log-rank, 0.7). Cumulative primary patency rates at 36 months were 38% in group 1 and 42%
in group 2 (P  .4; log-rank, 0.5). Assisted primary patency at 36 months was 45.1% in group 1 and 60.5% in group 2,
whereas secondary patency rates were 63.5% and 76%, respectively (P  .8; log-rank, 0.03).
Conclusion: Endovascular treatment of femoropopliteal occlusive disease provides similar results between men and
women at an intermediate follow-up. There is, however, a trend toward poorer results in women requiring further
analysis at a longer follow-up period. (J Vasc Surg 2012;55:105-12.)
Peripheral arterial occlusive disease (PAOD) in women
has been reported to be less frequent than in men1; how-
ever, arterial occlusive disease in women increases signifi-
cantly duringmenopause and after, and the incidence of the
disease in women and men in their sixth and seventh
decades has been reported to be at least identical.2 In spite
of these evidences, women have been demonstrated to have
less peripheral arterial disease (PAD)-related inpatient hos-
pitalizations and procedures than men.3 As a consequence,
it has been difficult to deeply analyze the impact of gender
on the results of femoropopliteal revascularizations. The
few studies in the literature concerning open surgical revascu-
larization report conflicting data, either supporting equivalent
long-term outcomes between men and women4 or recogniz-
ing female gender as a risk factor for adverse outcomes after
infrainguinal bypass surgery for limb salvage.5 When the re-
sults of endovascular procedures are examined, the paucity of
data becomes even greater: while few data do exist concerning
the outcomes of iliac endovascular interventions in females,6
we are aware of only one previous article reporting gender-
related perioperative and follow-up outcomes after infraingui-
nal peripheral angioplasty.7
Thepurposeof this studywas to retrospectively analyze early
and midterm results of endovascular infrainguinal peripheral re-
vascularizations in femalepatients inoursingle-centerexperience,
paying particular attention to clinical, anatomic, and technical
factors affecting perioperative and follow-up outcomes.
METHODS
From January 2000 to December 2010, 505 consecu-
tive endovascular procedures for PAOD in 480 patients
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were performed at our institution. Data concerning these
interventions were prospectively collected in a dedicated
institutional database containing main anatomic, clinical,
diagnostic, and technical variables. This database also con-
tains perioperative (30 days) results and all relevant clin-
ical and diagnostic data collected during follow-up.
A post-hoc analysis of this prospective database was
carried out and 258 interventions performed for femoro-
popliteal disease in 246 patients were found.
Interventions were retrospectively divided into two
groups: interventions performed in women (80 interven-
tions, group 1) and interventions performed in men (178
interventions, group 2).
The two groups of patients were compared in terms of
demographic data, common risk factors for atherosclerosis,
and comorbidities. Risk factors and comorbidities included
arterial hypertension (defined as blood pressure greater
than 130/80 mm Hg or the need for antihypertensive
drugs), hyperlipemia (defined as triglycerides and choles-
terol values 200 mg/dL), coronary artery disease (his-
tory of myocardial infarction, angina, previous coronary
revascularization), diabetes mellitus (defined as the need
for specific drugs), and chronic renal failure (defined as
the presence of serum creatinine values higher than 1.5
mg/mL).
Clinical status was defined on the basis of Rutherford’s
classification,8 while anatomic characteristics of the lesions
were defined on the basis of TransAtlantic Inter-Society
Consensus (TASC) II guidelines.9
Preoperative diagnostic assessment consisted of ankle-
brachial index (ABI) measurement and duplex scanning in
all the patients and computed tomography angiography of
the aorto-iliac and femoral-popliteal axes in selected cases.
In patients presenting with recent (14 days) worsen-
ing of symptoms or Rutherford class upgrade and the
evidence of thrombosis, preoperative catheter-directed
thrombolysis with urokinase (Urochinasi Crinos; Crinos
SPA, Milan, Italy) was attempted. Thrombolytic treatment
was administered in a bolus of 100,000 IU, followed by
continuous infusion with a delivery rate of 70,000 IU/
hour. In all the patients, 1.000 to 1.500 IU/hour of
sodium heparin were administered via the same catheter to
maintain values of activated partial thromboplastin time
(aPTT) two times higher than normal value.
Angiographic controls were performed daily or more,
when necessary, and lytic infusion lasted until patency of
occluded vessels was achieved or for a maximum of 3 days
when unsuccessful. Thrombolysis was defined successful in
the presence of restored patency of the targeted vessel, even
in the presence of significant residual stenosis, which was
routinely treated at the end of thrombolytic treatment.
All the interventions were performed by vascular sur-
geons in the operating room in the first period of the
experience and then in the angiographic suite, with the
patient under local anesthesia, supplemented with intrave-
nous sedation or analgesia when required.
The access to femoral-popliteal axis was gained via an
ipsilateral femoral approach in the presence of lesions in-
volving the medium and distal third of the superficial
femoral artery and/or popliteal and tibial vessels; when the
proximal part of the superficial femoral artery was involved,
contralateral access was performed. In cases of complex
lesions involving the femoral bifurcation, a hybrid approach
was performed in which a surgical femoral endarterectomy
with or without patch angioplasty was followed by endo-
vascular treatment of the infrainguinal lesion.
After the placement of the introducer sheath, adminis-
tration of 5000 IU of intravenous sodium heparin was
performed in all the cases.
In superficial femoral artery (SFA) long occlusive le-
sions, arterial recanalization was achieved inmost cases with
a subintimal technique followed by angioplasty and stent-
ing. In SFA short lesions, and after an initial intraluminal
angioplasty, a policy of self-expanding stenting as a bailout
procedure was adopted. In popliteal and below-the-knee
lesions, angioplasty was routinely performed and stenting
was limited only to selected cases when dissection of the
tibial vessels occurred.
Intraoperative and perioperative data included type of
access, procedure performed (isolated percutaneous translu-
minal angioplasty [PTA] or stenting), type, number and
length of stents, associated procedures (both surgical and
endovascular), concomitant treatment of outflow vessels,
and postoperative medical treatment (single or dual anti-
platelet therapy, or oral anticoagulants).
Early (intraoperative and 30 days) results were ana-
lyzed in terms of technical success (defined as a 20%
residual stenosis at completion angiography), conversion to
open surgery (defined as technical failure followed by im-
mediate surgical repair), primary patency (defined as unin-
terrupted patency without procedures performed on or at
the margin of the treated segment), secondary patency
(defined as restored patency through the original treated
segment), and, for patients with critical limb ischemia, limb
salvage (defined as the avoidance of above or below-knee
amputation).
The follow-up program consisted of clinical and duplex
scanning examination with ABI measurement within the
third postoperative month, at 6 and 12 months, and yearly
thereafter. All studies were performed using an Acuson
Sequoia 512 Ultrasound System (Acuson Corporation,
Mountain View, Calif) and followed the current guide-
lines.10
Loss of primary patency was diagnosed when ABI
deterioration was associated with duplex evidence of signif-
icant (70%) restenosis, requiring or not a secondary in-
tervention to maintain arterial patency, or thrombosis of
the treated segment.
Follow-up results were analyzed in terms of survival,
primary and secondary patency, assisted primary patency
(defined as the success of procedures carried out on a still
patent segment to prevent its thrombosis), and, for patients
with critical ischemia, limb salvage.
Statistical analysis was performed by means of SPSS
15.0 for Windows (SPSS, Chicago, Ill); early results were
analyzed with 2 test and Fisher exact test, when necessary.
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Follow-up data were analyzed by life-table analysis
(Kaplan-Meier test) and results in the two groups were
compared by means of the log-rank test. Univariate and
multivariate analysis (Cox regression) of the factors affect-
ing primary and secondary patency in the whole group were
performed. In Cox regression analysis, the factors with
statistical significance at univariate analysis were included.
Statistical significance was defined as a P value less than .05.
RESULTS
Demographic data, clinical, and anatomic status.
There were no differences between the two groups in terms
of risk factors for atherosclerosis and comorbidities, except
for a higher percentage of smokers and past-smokers
among men. Patients in group 1 were significantly older
than patients in group 2 at the time of intervention (Table
I). Interventions were performed for critical limb ischemia
in 40 cases (50%) in group 1 and in 73 cases (40.5%) in
group 2 (P  .1), while the remaining patients had severe
intermittent claudication. Also, the kind of arterial lesions
was similar in terms of TASC II classification; in group 1, 44
patients (55%) had TASC II C and D lesions, while the
corresponding value in group 2 was 58% (104 patients; P
.6). Rutherford and TASC II classifications in both groups
are reported in Table II. Overall mean preoperative ABI
was 0.42 (SD 0.23), and it was similar in group 1 and 2
(0.42  0.23 and 0.43  0.23, respectively; P  .7).
Operative details. In the whole study group, percuta-
neous contralateral femoral access was used in 190 cases; 47
patients had percutaneous ipsilateral femoral access, while
one patient had percutaneous brachial access. In 20 inter-
ventions, the ipsilateral open surgical femoral approach was
used. Female patients had more frequent contralateral ac-
cess (68 cases, 85%) than male patients (122 cases, 68.5%;
P  .02); in male patients, ipsilateral access was more
frequently used (41 cases, 23%) than in female patients (six
cases, 7.5%; P  .04). Open surgical femoral approach was
used in six women (7.5%) and in 14 men (8%; P .8). The
distribution of the treated arterial segments is reported in
Table III.
The lesions were successfully crossed in all but five
cases, one in group 1 and four in group 2.
Isolated PTA was performed in 34 cases in group 1
(42.5%) and in 61 cases in group 2 (34%; P  .4); in the
remaining 158 cases, one or more stents were placed. The
mean number of placed stents was 1.2 1.3 in group 1 and
1.3  1.2 in group 2 (P  .7); the mean length of treated
arterial segments was 100.8 81 mm in group 1 and 130
75 mm in group 2 (P  .08). Twenty different types of
commercially available stents were used; in 130 cases, ni-
tinol stents were used, and in 12 cases, a steel stent was
used, whereas the remaining 16 patients had a covered stent
placed. There were no differences between men and
women in the distribution of the different kinds of placed
stents (Table III).
In 24 patients (eight in group 1 and 18 in group 2) with
recent symptom impairments and angiographic evidence of
femoropopliteal occlusion, intra-arterial thrombolysis with
urokinase was performed. Mean duration of thrombolytic
treatment was 60 hours (range, 24-72 hours) and throm-
bolysis was successful in all but two cases. All the patients
were treated with PTA with or without a stent of the
targeted lesion within 24 hours from the cessation of
urokinase administration.
Concomitant open surgical interventions were per-
formed in 21 cases, six in group 1 and 15 in group 2 (P 
.8). In the 20 patients who had a surgical femoral approach,
the intervention consisted of femoral endarterectomy and
patching; one adjunctive male patient with critical limb
ischemia had the concomitant open repair of an 8-cm
abdominal aortic aneurysm.
In 27 cases (five in group 1 and 22 in group 2; P .2),
an associated endovascular procedure of the iliac arteries (in
all but one case ipsilateral) was performed; four of these
patients, all in group 2, were among those undergoing
femoral endarterectomy.
Postoperative medical treatment consisted of dual an-
tiplatelet therapy in 206 cases and of single antiplatelet
therapy in 39 cases; in 13 patients who took oral anticoag-
ulant before the procedure, the therapeutic regimen was
continued also after the discharge. There were no differ-
ences between the two groups in terms of postoperative
medical treatment.
Perioperative and early (<30 days) results. Technical
success was 96.9%. As already mentioned, in five cases (one
in group 1 and four in group 2), it was not possible to cross
the lesions. In three of these patients, surgical bypass was
Table I. Demographic data, risk factors, and
comorbidities
Group 1 Group 2
P value(80 int.) (178 int.)
Median age, years 75.3 71.5 .006
History of smoking 32 (40%) 156 (87.5%) .001
Hyperlipemia 49 (61%) 103 (58%) .7
Arterial hypertension 63 (78%) 134 (75%) .6
Diabetes mellitus 32 (40%) 71 (39%) .9
Coronary artery disease 26 (32.5%) 59 (33%) .9
Chronic renal failure 5 (6%) 15 (8.5%) .7
Int., At time of intervention.
Table II. Clinical and anatomic status
Group 1 Group 2
P value(80 int.) (178 int.)
Rutherford classification
Class 3 40 (50%) 105 (59.5%) .1
Class 4 15 (19%) 30 (17%) .7
Class 5 23 (29%) 38 (21%) .3
Class 6 2 (3%) 5 (2.5%) .8
TASC II classification
Type A 14 (17.5%) 29 (16%) .6
Type B 22 (28%) 45 (25%) .5
Type C 18 (22.5%) 53 (30%) .1
Type D 26 (32%) 51 (29%) .8
Int., At time of intervention; TASC, TransAtlantic Inter-Society Consensus.
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performed (immediate in two patients and delayed in one);
the remaining patients (one man and one woman) refused
the surgical option and were medically managed. Three
adjunctive male patients had intraoperative thrombosis of
the treated arterial segment and also underwent surgical
bypass (immediate in two cases and delayed in the remain-
ing one). Technical failure rates were 1.2% in group 1 and
3.9% in group 2 (P  .2).
Three in-hospital deaths were recorded, all in group 2,
in two cases due to acute myocardial infarction and to acute
respiratory failure in the other one. In-hospital thromboses
occurred in five patients, two in group 1 and three in group
2; conversion to surgical bypass was performed in all these
cases, and in three cases, major amputation was necessary
(two in group 1 and one in group 2). All the patients who
had an amputation had been operated on for critical limb
ischemia. One male patient developed a pseudoaneurysm
of the contralateral common femoral artery used for the
access and underwent open surgical repair.
At 30 days, neither adjunctive thromboses nor deaths
were recorded. Cumulative 30-day mortality was 1.1%,
with no difference between women (no deaths) and men
(three deaths, 1.6%; P .4). Overall amputation rate at 30
days was 1.2%, again with no differences between the two
groups (2.5% and 0.6%, respectively; P  .4); also the rate
of perioperative thrombosis (overall 2.7%) was similar be-
tween the two groups (2.5% and 3.3%, respectively; P .9).
Follow-up results. Mean duration of follow-up was
17 months (range, 1-85 months); 216 of the 233 patients
(93%) who had technical success had regular postoperative
follow-up visits.
During follow-up, 13 new deaths occurred, four in
group 1 and nine in group 2. The cause of death was cardiac
in eight cases and cancer in two cases; one patient suffered
from fatal acute respiratory failure, one patient died of an
acute accidental overdose of psychotropic drugs, and in the
remaining case, the death was caused by a car accident.
Estimated 36-month survival rates were 95% (SE 0.02) in
group 1 and 84.5% (SE 0.05) in group 2 (P  .4; log-rank
0.7).
Significant restenosis of the treated vessel occurred in
29 cases in the whole study group, 12 in group 1 and 17 in
group 2. In all but six cases, the restenosis was successfully
treated with new endovascular procedures, in 11 cases with
PTA, in five cases with stent placement, and in seven cases
with cutting-balloon. In the remaining patients, the reste-
nosis was asymptomatic and they were medically managed
without developing occlusion or clinical impairment dur-
ing follow-up.
Fifty-one new thromboses were recorded during follow-
up, 18 in group 1 and 33 in group 2. Patients with throm-
bosis were medically managed in 17 cases; a new endovas-
cular procedure was performed in 28 cases, whereas six
patients had direct conversion to open surgical bypass. In
12 of the 28 patients who had endovascular reinterven-
tions, further reinterventions for the development of novel
restenoses or occlusions were required (one more in five
cases, two more in four cases, and three more in three
cases). In four of these patients, conversion to open surgery
was necessary.
Five new amputations occurred, one in group 1 and
four in group 2, all in patients operated on for critical limb
ischemia; in one male patient, the amputation was per-
formed in spite of the patency of the treated arterial seg-
ment due to the wide extension of leg and foot ulcers.
Cumulative primary patency rates at 36 months were
38% (SE 0.07) in group 1 and 42% (SE 0.07), in group 2
(P  .4; log-rank 0.5; Fig 1).
Assisted primary patency at 36 months was 45.1% (SE
0.08) in group 1 and 60.5% (SE 0.07) in group 2 (P  .2;
log-rank 1.1; Fig 2), while secondary patency rates were
63.5% (SE 0.09) and 76% (SE 0.07), respectively (P  .8;
log-rank 0.03; Fig 3).
Thirty-six-month freedom from any (open or endovas-
cular) reintervention rates were 52.5% (SE 0.07) in group 1
and 51% (SE 0.08) in group 2 (P  .7; log-rank 0.2); the
rates of conversion to surgical bypass at 3 years were 14.9%
(SE 0.08) and 10.8% (SE 0.04), respectively (P  .6;
log-rank 0.3).
In patients with critical limb ischemia, limb salvage
rates at 36 months were 79% (SE 0.1) and 91% (SE 0.05),
respectively (P  .7; log-rank 0.2).
At univariate analysis, the presence of critical limb
ischemia and of TASC II C and D lesions were found to
Table III. Technical details
Group 1 Group 2
P value(80 int.) (178 int.)
Treated arterial segments
Superficial femoral 38 (47.5%) 78 (44%) .2
Superficial femoral and popliteal 9 (11%) 23 (13%) .7
Superficial femoral, popliteal, and tibial 27 (33.5%) 54 (30%) .8
Isolated tibial 6 (8%) 23 (13%) .09
Angioplasty alone 34/80 (42.5%) 61/180 (34%) .4
Type of stent
Nitinol 39/45 (86%) 91/113 (80%) .6
Steel 3/45 (7%) 9/113 (8%) .8
Covered stent 3/45 (7%) 13/113 (12%) .6
Int., At time of intervention.
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significantly affect long-term primary patency; at multivar-
iate analysis, only the presence of C and D lesions had
statistical significance (Table IV); as far as secondary pa-
tency is concerned, the presence of critical limb ischemia,
of TASC II C and D lesions, and the use of stents were
found to significantly affect it at univariate analysis, while at
multivariate analysis, only the presence of C andD lesions and
the use of stents maintained their significance (Table V).
DISCUSSION
Gender-related outcomes periodically turn out in the
scientific community and women are often considered at
higher risk of perioperative adverse events in different vas-
cular districts.11,12
In the everyday practice, it is well recognized that the
treatment of vascular lesions in women, particularly if they
are diabetics, is often challenging and technically demand-
ing, requiring skill and experience to treat them unevent-
fully.
Despite this anecdotal example, gender-related results
in patients affected by PAOD are reported in a conflicting
way. Nguyen et al5 investigated the role of race and gender
in a large trial enrolling patients with critical limb ischemia
undergoing femoropopliteal bypasses with vein. They con-
cluded that the synergism between the two investigated
factors could have led to worse outcomes in black female
subjects. On the other hand, in their review analyzing the
results of surgical infrainguinal revascularizations, Harthun
et al4 found contradictory reported results in women. In
fact, most of the examined studies were retrospective anal-
ysis from a single institution and, unfortunately, the major-
ity of those studies compared dissimilar patient group: only
two studies compared men and women who had no signif-
icant differences regarding age, smoking history, and inci-
dence of diabetes. In spite of these limits, the authors
concluded that there did not seem to be significant differ-
ences between men and women regarding the most impor-
tant outcome measurements (limb salvage, graft patency,
and mortality).
In recent years, the introduction and wide diffusion of
endovascular techniques has been changing the paradigm
of treatment of PAD, and endovascular surgery currently
allows the treatment of patients who once would have been
probably excluded from any possibility of revascularization.
For this reason, an endovascular approach has been sug-
gested as the first-line therapy in most patients, even if the
recently published bypass versus angioplasty in severe isch-
emia of the leg trial13 raised some concerns about the
long-term durability of endovascular procedures. A direct
consequence of this increase in endovascular procedures is
the reduction of gender-related disparities in the treatment
and outcomes of PAD, leading to an overall improvement
of results also in women.3 In spite of this fact, however,
there are few data in the literature analyzing the influence of
gender on the results of endovascular treatment of PAD. A
recent revision of a large multistate database3 analyzed the
rate of in-hospital mortality after endovascular interven-
tions and found a significant higher mortality in women
than in men, even in the presence of significant improve-
Fig 2. Kaplan-Meier curve for assisted primary patency during
follow-up with numbers of patients at risk and standard error (SE).
Fig 1. Kaplan-Meier curve for primary patency during follow-up
with numbers of patients at risk and standard error (SE).
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ments of the results during the years; however, the analysis
did not separate between aortoiliac and femoropopliteal
localizations and othermain outcomes (such as patency and
limb salvage rates) were not considered in the results. The
same limits are present in another monocentric study,14
where women were not found to have a significantly higher
perioperative mortality in comparison with men; however,
women had a greater than 10-fold higher risk of hemor-
rhagic complications. Finally, Timaran et al6 found that the
female gender was among the independent predictors of
poor outcome after iliac stenting in patients with anatom-
ically complex lesions, suggesting a persistent role for open
Fig 3. Kaplan-Meier curve for secondary patency during follow-up with numbers of patients at risk and standard
error (SE).
Table IV. Univariate and multivariate analysis of factors affecting primary patency in the whole group
Univariate analysis Multivariate analysis
Log-rank P value 95% CI OR 95% CI OR P value
Female gender 0.5 .4 0.7-1.8 1.1
Chronic renal failure 1.7 .4 0.3-1.8 0.8
Diabetes 1.7 .4 0.1-1.8 0.4
Critical limb ischemia 3.3 .05 0.9-2.3 1.5 0.7-1.8 1.1 .5
TASC C-D vs A-B lesions 9.6 .002 1.2-3.3 2 1.1-3.3 1.9 .01
Stent placement 0.9 .3 0.7-2 1.2
Treated limited to the SFA 0.4 .5 0.5-1.3 0.8
Single vs double antiplatelet treatment 2.5 .09 0.8-3.4 1.6
CI, Confidence interval; OR, odds ratio; SFA, superficial femoral artery; TASC, TransAtlantic Inter-Society Consensus.
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surgery in this setting. Also, in our previous report on
endovascular management of iliac stenosis and occlusion,
we found an increased risk of thrombosis in female patients
at univariate analysis, even if this rate was not statistically
significant.15
In this study, we have analyzed the effect of gender on
the results of endovascular procedures in patients with
infrainguinal disease, and, to the best of our knowledge,
there is only one other article in the literature making such an
analysis. In fact, DeRubertis et al7 compared the results of
447 endovascular procedures performed in women with
those obtained in 553 procedures performed in men.
In our series, female patients were older than the male
patients at the time of the intervention, and this is a
common finding in the literature,3,7,16 whereas men more
frequently had a history of smoking. No other significant
differences were found in terms of comorbidities, risk fac-
tors, or clinical and anatomic status between the two groups,
even if there was a trend toward a higher percentage of
patientswith critical limb ischemia amongwomen, similarly to
what was reported in the article from DeRubertis et al.7 Also,
the technical details and the intraoperative strategy did not
differ between the two groups, thus guaranteeing the homo-
geneity of the groups and the reliability of our results. Periop-
erative and early resultswere satisfactory,with an excellent rate
of technical success and significant hemodynamic improve-
ment in both groups; men had a trend toward poorer techni-
cal success rates, while women had a higher percentage of
perioperative amputations. Of interest is the observation that
both women with perioperative thrombosis underwent major
amputation, while this occurred in only one of six men. This
finding could suggest that the rescue of acutely thrombosed
segments is more difficult among women; however, the lim-
ited number of events does not allow us to draw any firm
conclusion in this sense.
Follow-up results demonstrated satisfactory primary,
assisted primary, and secondary patency rates, with no
statistical difference between the groups. These results are
similar with those in other series,7 where no differences in
terms of primary and secondary patency and limb salvage
rates between women andmen were reported, even though
women tend to present with more severe infrainguinal
occlusive disease than men. Also the rates of amputations
and conversions to surgical bypass were similar in our series,
suggesting the safety and the effectiveness of the endovas-
cular approach also in women. However, even if primary and
assisted primary patency rates did not reach a statistical signif-
icance, there was a trend for poorer primary and assisted
primary patency rates in women (possible type 1 statistical
error). One can suppose that at a longer follow-up timewith a
larger number of patients and events, this difference becomes
significant, suggesting the need for deeper and longer analysis.
As expected, subgroup analysis demonstrated that
the anatomic complexity of the lesions is the main pre-
dictor of follow-up outcomes; interestingly, the use of a
stent was associated with poorer secondary patency rates
during follow-up. The explanation of this result is difficult;
although several studies suggested the benefit of stenting in
comparison with PTA alone in early and long-term out-
comes,17 a recent article from Robinson et al18 did not
report any correlation between procedural characteristics
and secondary patency rates in patients undergoing re-
peated endovascular procedures. Our observation, how-
ever, seems to confirm what most surgeons can observe in
their everyday practice, that it is really difficult to deal with
thrombosed stents at the femoropopliteal level.
This study has several limits; it is a retrospective mono-
centric study, with a limited number of patients and events,
and a still short mean follow-up time. On the other hand, in
our opinion, its strength lies beyond the novelty of the
topic, also in the clinical and anatomic homogeneity of the
two groups, allowing a significant comparison between
them.
CONCLUSIONS
Endovascular treatment of femoropopliteal occlusive
disease provides similar results between men and women at
an intermediate follow-up. There is, however, a trend to-
ward poorer results in women, requiring further analysis at
a longer follow-up period.
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